A three-gene signature and clinical outcome in pediatric acute myeloid leukemia

被引：0
|
作者：
Z. Cai
Y. Wu
F. Zhang
H. Wu
机构：
[1] The First Affiliated Hospital of University of South China,Department of Pediatrics
[2] The First People’s Hospital of Xiangtan City,Department of Pathology
[3] The Rushan People’s Hospital of Weihai City,Department of Pathology
来源：
Clinical and Translational Oncology | 2021年 / 23卷
关键词：
Pediatric; AML; Prognosis; LASSO; GSEA;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：866 / 873
页数：7
相关论文
共 50 条
  • [31] Identifying a novel 5-gene signature predicting clinical outcomes in acute myeloid leukemia
    K. Sha
    Y. Lu
    P. Zhang
    R. Pei
    X. Shi
    Z. Fan
    L. Chen
    Clinical and Translational Oncology, 2021, 23 : 648 - 656
  • [32] Identifying a novel 5-gene signature predicting clinical outcomes in acute myeloid leukemia
    Sha, K.
    Lu, Y.
    Zhang, P.
    Pei, R.
    Shi, X.
    Fan, Z.
    Chen, L.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (03): : 648 - 656
  • [33] Pharmacogenomics, Race, and Treatment Outcome in Pediatric Acute Myeloid Leukemia
    Lamba, Jatinder K.
    Marrero, Richard
    Wu, Huiyun
    Cao, Xueyuan
    Parcha, Phani Krisha
    Karol, Seth E.
    Inaba, Hiroto
    Kuo, Dennis John
    Degar, Barbara A.
    Heym, Kenneth
    Taub, Jeffrey W.
    Lacayo, Norman J.
    Pui, Ching-Hon
    Ribeiro, Raul C.
    Pounds, Stanley B.
    Rubnitz, Jeffrey E.
    JAMA NETWORK OPEN, 2024, 7 (05) : E2411726
  • [34] A Three-Gene Signature for Outcome in Soft Tissue Sarcoma (vol 15, pg 5191, 2009)
    Hoffmann, Andreas-Claudius
    CLINICAL CANCER RESEARCH, 2009, 15 (20) : 6472 - 6472
  • [35] Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherapy
    Kim, H. K.
    Choi, I. J.
    Kim, C. G.
    Kim, H. S.
    Oshima, A.
    Yamada, Y.
    Arao, T.
    Nishio, K.
    Michalowski, A.
    Green, J. E.
    PHARMACOGENOMICS JOURNAL, 2012, 12 (02): : 119 - 127
  • [36] Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherapy
    H K Kim
    I J Choi
    C G Kim
    H S Kim
    A Oshima
    Y Yamada
    T Arao
    K Nishio
    A Michalowski
    J E Green
    The Pharmacogenomics Journal, 2012, 12 : 119 - 127
  • [37] Study of clinical outcome and prognosis in pediatric core binding factor-acute myeloid leukemia
    吴珺
    ChinaMedicalAbstracts(InternalMedicine), 2019, 36 (03) : 181 - 182
  • [38] Clinical features, complications, and early treatment outcome of pediatric acute myeloid leukemia with hyperleukocytosis.
    Inaba, Hiroto
    Fan, Ying
    Pounds, Stanley
    Rubnjtz, Jeffrey E.
    Ribeiro, Raul C.
    Pui, Ching-Hon
    Razzouk, Bassern I.
    BLOOD, 2006, 108 (11) : 205B - 205B
  • [39] A Three-Gene Signature Predicts Response to Selinexor in Multiple Myeloma
    Restrepo, Paula
    Bhalla, Sherry
    Ghodke-Puranik, Yogita
    Aleman, Adolfo
    Leshchenko, Violetta
    Melnekoff, David T.
    Agte, Sarita
    Jiang, Joy
    Madduri, Deepu
    Richter, Joshua
    Richard, Shambavi
    Chari, Ajai
    Cho, Hearn Jay
    Jagannath, Sundar
    Walker, Christopher J.
    Landesman, Yosef
    Lagana, Alessandro
    Parekh, Samir
    JCO PRECISION ONCOLOGY, 2022, 6
  • [40] A novel necroptosis-related gene signature in acute myeloid leukemia
    Fang, Weiyue
    Lin, Hongdou
    Chen, Junyi
    Guo, Wenjian
    HEMATOLOGY, 2023, 28 (01)
12345